ASC Regulates Subcutaneous Adipose Tissue Lipogenesis and Lipolysis via p53/AMPKα Axis

Hong Chen, Qilin Pei, Linfen Tao, Jing Xia, Guocai Lu, Ying Zong, Wenhua Xie, Wanqing Li, Chenglong Huang, Ting Zeng, Xinyu Yu, Weixuan Wang, Gaojun Chen, Yang Song, Rui Cheng, Xi LiInternational Journal of Molecular Sciences 2022 · DOI

TL;DR

This study reveals that the protein ASC, previously known for its role in inflammation and apoptosis, plays a crucial role in regulating fat metabolism in subcutaneous adipose tissue. ASC deficiency leads to increased fat storage and impaired lipid breakdown by influencing the p53/AMPKα pathway, suggesting ASC as a potential therapeutic target for obesity.

What Problem Does This Paper Address?

Obesity is a major global health challenge linked to chronic inflammation and metabolic diseases. Adipose tissue is central to energy homeostasis, balancing the processes of lipogenesis (fat storage) and lipolysis (fat breakdown). While the inflammasome protein ASC is known to be involved in inflammation and apoptosis, its role in lipid metabolism, particularly in adipose tissue, remained unclear. This paper aims to elucidate ASC's function in regulating lipogenesis and lipolysis, and to uncover the molecular mechanisms by which it influences these processes, potentially offering new avenues for obesity treatment.

Methods

The researchers employed a multi-pronged approach:

  • In vivo studies: They used high-fat diet (HFD)-induced obese mice and Asc gene knockout (Asc<sup>-/-</sup>) mice, along with their littermate controls (LM), to investigate ASC expression and its impact on body weight, fat distribution, glucose tolerance, and insulin sensitivity.
  • In vitro studies: They isolated stromal vascular fractions (SVF) from adipose tissue and differentiated them into pre-adipocytes. These cells were then used to study the effects of ASC deficiency (using Asc<sup>-/-</sup> SVF or ASC siRNA in wild-type SVF) on lipogenesis and lipolysis.
  • Molecular analysis: Techniques like Western blotting and RT-qPCR were used to measure the expression levels of ASC, key lipogenic and lipolytic enzymes (e.g., ACC, FASN, HSL, ATGL), and signaling molecules (p53, AMPKα).
  • Pathway investigation: To understand the mechanism, they used activators of p53 (Kevetrin) and AMPKα (AICAR) to see if they could reverse the effects of ASC deficiency.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from mouse models and cell cultures.

Key Insights and Ideas

  • ASC's unexpected role in fat metabolism: Beyond inflammation, ASC is a key regulator of lipid metabolism in subcutaneous adipose tissue.
  • ASC deficiency exacerbates obesity: Loss of ASC leads to increased fat accumulation and impaired metabolic health, even in the absence of overt inflammation.
  • The p53/AMPKα axis is central: ASC appears to exert its control over lipogenesis and lipolysis by modulating the p53 and AMPKα signaling pathways.
  • Fasting and refeeding influence ASC: ASC expression in adipose tissue changes with feeding status, suggesting its involvement in dynamic energy balance.

Key Results

  • ASC expression correlates with obesity: ASC levels were significantly upregulated in the subcutaneous adipose tissue (SAT) of HFD-fed and ob/ob mice.
  • ASC deficiency promotes fat storage: Asc<sup>-/-</sup> mice showed increased lipogenesis (upregulation of ACC, FASN, FABP4) and decreased lipolysis (downregulation of p-HSL, HSL, ATGL) in SAT. This was also observed in Asc<sup>-/-</sup> SVF cells.
  • Metabolic dysfunction in Asc<sup>-/-</sup> mice: These mice exhibited impaired glucose tolerance and insulin sensitivity, along with increased serum cholesterol and free fatty acids.
  • Mechanism elucidated: ASC deficiency led to decreased expression of p53 and AMPKα. Activating these pathways with AICAR and Kevetrin partially reversed the lipogenic effects of ASC deficiency.
  • Fasting increases ASC: ASC expression in SAT was upregulated during fasting and returned to normal upon refeeding, suggesting a role in energy adaptation.

Limitations and Future Work

The authors acknowledge several limitations:

  • Lack of human ASC deficiency data: The study did not include human patients with ASC deficiency due to its rarity and limited access to samples. Future work should aim to include human data.
  • Focus on deficiency: The current study focused on ASC deficiency. Further research is needed to investigate the effects of ASC overexpression on lipid metabolism.

The study suggests that ASC's role in regulating lipid metabolism via the p53/AMPKα axis presents a promising new therapeutic target for obesity and related metabolic disorders.

Summary updated

Abstract

Obesity has become an extensive threat to human health due to associated chronic inflammation and metabolic diseases. Apoptosis-associated speck-like protein (ASC) is a critical link between inflammasome and apoptosis-inducing proteins. In this study, we aimed to clarify the role of ASC in lipid metabolism. With high-fat diet (HFD) and knockout leptin gene mice (<i>ob</i>/<i>ob</i>), we found that ASC expression in subcutaneous adipose tissue (SAT) correlated with obesity. It could also positively regulate the reprogramming of cellular energy metabolism. Stromal vascular fractions (SVF) cells derived from the SAT of <i>Asc<sup>-/-</sup></i> mice or SVF from wild-type (WT) mice transfected with ASC siRNA were used to further investigate the underlying molecular mechanisms. We found ASC deficiency could lead to lipogenesis and inhibit lipolysis in SAT, aggravating lipid accumulation and impairing metabolic balance. In addition, our results showed that p53 and AMPKα expression were inhibited in SAT when ASC level was low. p53 and AMP-activated protein kinase α (AMPKα) were then assessed to elucidate whether they were downstream of ASC in regulating lipid metabolism. Our results revealed that ASC deficiency could promote lipid accumulation by increasing lipogenesis and decreasing lipolysis through p53/AMPKα axis. Regulation of ASC on lipid metabolism might be a novel therapeutic target for obesity.
BibTeX
@article{chen2022asc,
  author = {Hong Chen and Qilin Pei and Linfen Tao and Jing Xia and Guocai Lu and Ying Zong and Wenhua Xie and Wanqing Li and Chenglong Huang and Ting Zeng and Xinyu Yu and Weixuan Wang and Gaojun Chen and Yang Song and Rui Cheng and Xi Li},
  title = {{ASC Regulates Subcutaneous Adipose Tissue Lipogenesis and Lipolysis via p53/AMPKα Axis}},
  journal = {International Journal of Molecular Sciences},
  year = {2022},
  doi = {10.3390/ijms231710042},
}
Figure